Company intelligence / Profile preview

Heart Rhythm Technology

Temecula, California, United States

Ownership: Private
Development stage: Other

Overview

Heart Rhythm Technology (HRT) was a pioneering medical device company specializing in the electrophysiology market, specifically the diagnosis and treatment of cardiac arrhythmias. Originally acquired by Eli Lilly in 1992, it became one of the five core operating units of Guidant Corporation upon its spin-off in 1994. The company developed advanced intracardiac mapping systems and ablation catheters that enabled electrophysiologists to visualize and treat complex heart rhythm disorders with high precision. Following the acquisition of Guidant by Boston Scientific in 2006, HRT's technologies were integrated into Boston Scientific's broader cardiac rhythm management portfolio.

Therapeutic areas: Cardiovascular
Modalities: Device
Industry: Physiological Monitoring

Beyond the preview

Go deeper on Heart Rhythm Technology.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Heart Rhythm Technology.

Explore the full profile